medigraphic.com
ISSN 2448-5640 (Impreso)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2023, Número 4

Siguiente >>

Cir Card Mex 2023; 8 (4)


Transcatheter-edge-to-edge for mitral valve regurgitation: Experientia docet

García-Villarreal OA

Idioma: Ingles.
Referencias bibliográficas: 38
Paginas: 89-93
Archivo PDF: 318.44 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hausleiter J, Lim D, Gillam L, et al. Transcatheter Edge-to-Edge Repair in Patientswith Anatomically Complex Degenerative Mitral Regurgitation. J Am CollCardiol. 2023;81(5):431– 442. doi: 10.1016/j.jacc.2022.11.034.

  2. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions inthe real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter,nonrandomized post-approval study of the MitraClip therapy in Europe. JAm Coll Cardiol. 2013;62(12):1052-1061. doi: 10.1016/j.jacc.2013.02.094.

  3. Feldman T, Kar S, Elmariah S, et al; EVEREST II Investigators. RandomizedComparison of Percutaneous Repair and Surgery for Mitral Regurgitation:5-Year Results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844-2854. doi:10.1016/j.jacc.2015.10.018.

  4. Obadia JF, Messika-Zeitoun D, Leurent G, et al.; MITRA-FR Investigators. PercutaneousRepair or Medical Treatment for Secondary Mitral Regurgitation. N EnglJ Med. 2018;379(24):2297-2306. doi: 10.1056/NEJMoa1805374.

  5. Stone GW, Lindenfeld J, Abraham WT, et al; COAPT Investigators. TranscatheterMitral-Valve Repair in Patients with Heart Failure. N Engl J Med.2018;379(24):2307-2318. doi: 10.1056/NEJMoa1806640.

  6. Adamo M, Grasso C, Capodanno D, et al. Five-year clinical outcomes after percutaneousedge-to-edge mitral valve repair: Insights from the multicenter GRASP-ITregistry. Am Heart J. 2019;217:32-41. doi: 10.1016/j.ahj.2019.06.015.

  7. Sürder D, Klersy C, Corti R, et al; Collaborators. Impact of mitral regurgitationaetiology on MitraClip outcomes: the MitraSwiss registry. EuroIntervention.2020;16(2):e112-e120. doi: 10.4244/EIJ-D-19-00718.

  8. Bedogni F, Popolo Rubbio A, Grasso C, et al. Italian Society of Interventional Cardiology(GIse) registry Of Transcatheter treatment of mitral valve regurgitaTiOn(GIOTTO): impact of valve disease aetiology and residual mitral regurgitation afterMitraClip implantation. Eur J Heart Fail. 2021;23(8):1364-1376. doi: 10.1002/ejhf.2159.

  9. Mack MJ, Lindenfeld J, Abraham WT, et al; COAPT Investigators. 3-Year Outcomesof Transcatheter Mitral Valve Repair in Patients with Heart Failure. J AmColl Cardiol. 2021;77(8):1029-1040. doi: 10.1016/j.jacc.2020.12.047.

  10. Real World Expanded Multicenter Study of the MitraClip® System (REALISM)(REALISM). ClinicalTrials.gov Identifier: NCT01931956. available at: https://clinicaltrials.gov/ct2/show/results/NCT01931956

  11. Mack M, Carroll JD, Thourani V, et al. Transcatheter Mitral Valve Therapy inthe United States: A Report from the STS/ACC TVT Registry. Ann Thorac Surg.2022;113(1):337-365. doi: 10.1016/j.athoracsur.2021.07.030.

  12. Kavsur R, Spieker M, Iliadis C, et al; of the Heart Failure Network Rhineland.Mitral Regurgitation International Database (MIDA) Score Predicts Outcome inPatients with Heart Failure Undergoing Transcatheter Edge-to-Edge Mitral ValveRepair. J Am Heart Assoc. 2021;10(13):e019548. doi: 10.1161/JAHA.120.019548.

  13. Pighi M, Estevez-Loureiro R, Maisano F, et al; Transcatheter Valve TreatmentSentinel Registry (TCVT) Investigators of the EURObservational ResearchProgramme (EORP) of the European Society of Cardiology. Immediate and12-Month Outcomes of Ischemic Versus Nonischemic Functional Mitral Regurgitationin Patients Treated with MitraClip (from the 2011 to 2012 Pilot SentinelRegistry of Percutaneous Edge-To-Edge Mitral Valve Repair of the EuropeanSociety of Cardiology). Am J Cardiol. 2017;119(4):630-637. doi: 10.1016/j.amjcard.2016.10.049.

  14. Gillinov M, Burns DJP, Wierup P. The 10 Commandments for Mitral Valve Repair.Innovations (Phila). 2020;15(1):4-10. doi: 10.1177/1556984519883875.

  15. Stone GW, Adams DH, Abraham WT, et al; Mitral Valve Academic Research Consortium(MVARC). Clinical Trial Design Principles and Endpoint Definitions forTranscatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions:A Consensus Document from the Mitral Valve Academic Research Consortium. JAm Coll Cardiol. 2015;66(3):308-321. doi: 10.1016/j.jacc.2015.05.049.

  16. Buzzatti N, De Bonis M, Denti P, et al. What is a "good" result after transcathetermitral repair? Impact of 2+ residual mitral regurgitation. J Thorac CardiovascSurg. 2016;151(1):88-96. doi: 10.1016/j.jtcvs.2015.09.099.

  17. Sugiura A, Kavsur R, Spieker M, et al. Recurrent Mitral Regurgitation AfterMitraClip: Predictive Factors, Morphology, and Clinical Implication. CircCardiovasc Interv. 2022 Mar;15(3):e010895. doi: 10.1161/CIRCINTERVENTIONS.121.010895.

  18. Buzzatti N, Denti P, Scarfò IS, Giambuzzi I, Schiavi D, Ruggeri S, CastiglioniA, De Bonis M, La Canna G, Alfieri O. Mid-term outcomes (up to 5 years) ofpercutaneous edge-to-edge mitral repair in the real-world according to regurgitationmechanism: A single-center experience. Catheter Cardiovasc Interv. 2019 Sep1;94(3):427-435. doi: 10.1002/ccd.28029.

  19. García-Villarreal OA. Residual mitral regurgitation grade 2+ after transcatheteredge-to-edge mitral valve repair: Epic fail? Cardiovasc Metab Sci. 2022; 33 (4):181-86. doi: 10.35366/109245.

  20. Carpentier A. La valvuloplastie reconstructive. Une nouvelle technique de valvuloplastiemitrale [Reconstructive valvuloplasty. A new technique of mitral valvuloplasty].Presse Med (1893). 1969;77(7):251-3. [French].

  21. Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation forcorrection of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg.1971;61(1):1-13.

  22. Carpentier A. Cardiac valve surgery--the "French correction". J Thorac CardiovascSurg. 1983;86(3):323-37.

  23. Carpentier A, Adams DH, Filsoufi F. Carpentier's Reconstructive Valve Surgery.From valve analysis to valve reconstruction. Saunders Ed. 1st Edition - February23, 2010. Philadelphia, Penn, USA.

  24. Suri RM, Clavel MA, Schaff HV, et al. Effect of Recurrent Mitral RegurgitationFollowing Degenerative Mitral Valve Repair: Long-Term Analysis ofCompeting Outcomes. J Am Coll Cardiol. 2016;67(5):488-98. doi: 10.1016/j.jacc.2015.10.098.

  25. Nardi P, Pellegrino A, Scafuri A, et al. Survival and durability of mitral valve repairsurgery for degenerative mitral valve disease. J Card Surg. 2011;26(4):360-6.doi: 10.1111/j.1540-8191.2011.01275.x.

  26. Shimokawa T, Kasegawa H, Katayama Y, et al. Mechanisms of recurrent regurgitationafter valve repair for prolapsed mitral valve disease. Ann Thorac Surg.2011;91(5):1433-8; discussion 1438-9. doi: 10.1016/j.athoracsur.2011.01.015.

  27. Gillinov AM, Tantiwongkosri K, Blackstone EH, Houghtaling PL, Nowicki ER,Sabik JF 3rd, Johnston DR, Svensson LG, Mihaljevic T. Is prosthetic anuloplastynecessary for durable mitral valve repair? Ann Thorac Surg. 2009;88(1):76-82.doi: 10.1016/j.athoracsur.2009.03.089.

  28. David TE, David CM, Tsang W, Lafreniere-Roula M, Manlhiot C. Long-TermResults of Mitral Valve Repair for Regurgitation Due to Leaflet Prolapse. J AmColl Cardiol. 2019;74(8):1044-1053. doi: 10.1016/j.jacc.2019.06.052.

  29. Denti P, Buzzati N, Maisano F. Future Perspectives of the Edge-to-Edge Repair.Annuloplasty. In, Alfieri O, De Bonis M, LaCanna G (eds). Edge to edge mitralrepair. From a surgical to a percutaneous approach. Springer International PublishingSwitzerland 2015.

  30. De Bonis M, Lapenna E, Taramasso M, et al. Very long-term durability of the edgeto-edge repair for isolated anterior mitral leaflet prolapse: up to 21 years of clinicaland echocardiographic results. J Thorac Cardiovasc Surg. 2014;148(5):2027-32.doi: 10.1016/j.jtcvs.2014.03.041.

  31. De Bonis M, Lapenna E, Maisano F, Barili F, La Canna G, Buzzatti N, PappalardoF, Calabrese M, Nisi T, Alfieri O. Long-term results (≤18 years) of the edge-toedgemitral valve repair without annuloplasty in degenerative mitral regurgitation:implications for the percutaneous approach. Circulation. 2014;130(11 Suppl1):S19-24. doi: 10.1161/CIRCULATIONAHA.113.007885.

  32. De Bonis M, Lapenna E, Taramasso M, Pozzoli A, La Canna G, Calabrese MC,Alfieri O. Is commissural closure associated with mitral annuloplasty a durabletechnique for the treatment of mitral regurgitation? A long-term (≤15 years) clinicaland echocardiographic study. J Thorac Cardiovasc Surg. 2014;147(6):1900-6.doi: 10.1016/j.jtcvs.2013.07.009.

  33. De Bonis M, Lapenna E, Lorusso R, et al. Very long-term results (up to 17 years)with the double-orifice mitral valve repair combined with ring annuloplasty fordegenerative mitral regurgitation. J Thorac Cardiovasc Surg. 2012;144(5):1019-24. doi: 10.1016/j.jtcvs.2012.07.034.

  34. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitralvalve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg2001; 122:674–681. doi: 10.1067/mtc.2001.117277.

  35. Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midtermresults of edge-to-edge mitral valve repair without annuloplasty. J Thorac CardiovascSurg. 2003;126(6):1987-97. doi: 10.1016/s0022-5223(03)01291-1.

  36. De Bonis M, Lapenna E, Pozzoli A, Giacomini A, Alfieri O. Edge-to-edge surgicalmitral valve repair in the era of MitraClip: what if the annuloplasty ring is missed?Curr Opin Cardiol. 2015;30(2):155-160. doi: 10.1097/HCO.0000000000000148.

  37. Vassileva CM, Mishkel G, McNeely C, et al. Long-term survival of patients undergoingmitral valve repair and replacement: a longitudinal analysis of Medicarefee-for-service beneficiaries. Circulation. 2013;127(18):1870-6. doi: 10.1161/CIRCULATIONAHA.113.002200.

  38. Life Expectancy Calculator. Available at: https://www.ssa.gov/oact/population/longevity.html.




2020     |     www.medigraphic.com